L. Dubourg et al., Failure of the loop diuretic torasemide to improve renal function of hypoxemic vasomotor nephropathy in the newborn rabbit, PEDIAT RES, 47(4), 2000, pp. 504-508
The use of diuretic therapy in vasomotor nephropathy is a controversial top
ic. It is generally agreed that diuretics in this situation enhance urinary
output, reduce the degree of volume expansion, and improve cardiac and esp
ecially the compromised lung function. It is less clear whether diuretic th
erapy improves kidney function. The present study evaluates the effects of
intravenous torasemide on renal function in 25 anesthetized ventilated hypo
xemic newborn New Zealand White rabbits with vasomotor nephropathy. This we
ll-established animal model mimics the renal physiology of the human newbor
n and, in particular, that of the premature infant. Three groups of hypoxem
ic rabbits were studied. The animals of group 1 (n = 8) received no diureti
c therapy (hypoxemic control), and those of group 2 (n = 9) mere given a si
ngle intravenous dose of torasemide (1 mg/kg) in a curative fashion 2 h aft
er hypoxemia was induced. In the third group of animals (n = 8), torasemide
was gh en preventively; a bolus intravenous dose of torasemide (0.2 mg/kg)
was given before the induction of hypoxemia and sustained by the addition
of 0.2 mg.kg(-1).h(-1) of the drug to the continuous intravenous infusion g
iven throughout the entire 3-h hypoxemic period. Hypoxemia alone (group 1)
caused acute renal insufficiency with a significant fall in mean arterial b
lood pressure, GFR, and renal blood flow; the renal vascular resistance inc
reased, and the filtration fraction was unchanged. The curative dose of tor
asemide (group 2) induced a significant diuresis and natriuresis with minim
al augmentation of urinary potassium excretion, converting mildly oliguric
to nonoliguric acute renal insufficiency. In this group of animals, torasem
ide did not improve the glomerular dysfunction. The preventive dose of tora
semide (group 3) even somewhat worsened the already impaired tend functions
without further increasing the diuretic effect of the drug. We conclude th
at in hypoxemic newborn animals with renal dysfunction, torasemide is an ef
fective potassium-sparing diuretic that unfortunately does not improve rena
l blood flow and GFR, The failure of torasemide to attenuate the glomerular
dysfunction of hypoxemic vasomotor nephropathy in the newborn rabbit is di
sturbing. These data certainly caution against the overzealous use of loop
diuretics in hypoxemic oliguric neonates.